TLDR
- ARK Invest purchased 78,096 shares of Roblox worth $7.9 million across multiple ETFs on November 18, 2025
- The fund sold 203,244 Pinterest shares for $5.19 million, extending a pattern of social media stock reductions
- ARK invested $3.25 million in Klarna and $3.07 million in Circle Internet Group to boost fintech holdings
- Teradyne saw the second-largest sale at $7.2 million as ARK reduced chip-testing equipment exposure
- Biotech additions included $2.09 million in Recursion Pharmaceuticals and $2.64 million in CRISPR Therapeutics
Cathie Wood’s ARK Invest made portfolio adjustments on November 18, 2025, with Roblox receiving the largest investment. The fund purchased 78,096 shares worth $7.9 million through the ARK Innovation ETF and ARK Fintech Innovation ETF.
The Roblox purchase continues ARK’s pattern of increasing its stake in the gaming platform. This transaction represents the fund’s ongoing commitment to digital entertainment and metaverse-related companies.
ARK sold 203,244 Pinterest shares valued at $5.19 million on the same day. The sale marks another step in the fund’s retreat from social media investments.
The Pinterest reduction follows multiple recent sales. On November 17, ARK offloaded 24,220 Pinterest shares worth $618,000 alongside 16,540 Reddit shares valued at $3.1 million.
ARK also sold 11,447 Reddit shares for $2.15 million on November 18. The combined social media reductions show Wood’s shifting allocation strategy away from these platforms.
Fintech Sector Expansion
ARK purchased 93,218 Klarna shares for $3.25 million in fintech buying activity. The payment technology company addition expands the fund’s exposure to digital financial services.
Circle Internet Group received a $3.07 million investment through a 40,071 share purchase. The transaction builds on ARK’s recent accumulation of the company’s stock.
The fund bought 11,620 Coinbase shares as well. This purchase maintains ARK’s position in cryptocurrency exchange platforms and blockchain infrastructure.
Shopify received $4.76 million from ARK through the purchase of 33,992 shares. The e-commerce platform investment increases the fund’s retail technology holdings.
Biotech and Technology Trades
ARK invested $2.09 million in Recursion Pharmaceuticals by purchasing 50,728 shares. The drug discovery company represents part of the fund’s biotech strategy.
CRISPR Therapeutics received $2.64 million from ARK with a 47,751 share purchase. The gene-editing company investment adds to the fund’s life sciences portfolio.
Teradyne experienced the second-largest sale of the day. ARK sold 43,008 shares of the semiconductor testing equipment maker for $7.2 million.
The Teradyne reduction decreases ARK’s exposure to chip testing hardware. This move reallocates capital away from semiconductor equipment manufacturers.
All trades were executed on November 18, 2025, and disclosed through ARK’s daily trading reports. The fund operates several ETFs focused on disruptive innovation across technology, healthcare, and financial sectors.
The trading activity shows Wood’s current investment priorities. Gaming, fintech, e-commerce, and biotech received increased allocations while social media and hardware testing saw reductions.
ARK Invest manages billions in assets across its family of exchange-traded funds. The daily trades provide transparency into the fund’s positioning and sector preferences.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
